Treatment of the patient after myocardial infarction. The last decade and the next.
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D001241:Aspirin / Q000627:therapeutic use; D003645:Death, Sudden; D005081:Exercise Therapy; D006801:Humans; D009203:Myocardial Infarction / Q000175:diagnosis / Q000534:rehabilitation / Q000628:therapy*; D009204:Myocardial Revascularization; D011379:Prognosis; D013442:Sulfinpyrazone / Q000627:therapeutic use
D000319:Adrenergic beta-Antagonists; D001241:Aspirin; D013442:Sulfinpyrazone